medicasolution

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No.

With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of P

Mediomics, LLC has received an additional $460,000 in a renewal of its 2nd year STTR Phase II grant (R42GM079891) from the National Institute of General Medical Sciences.

Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD).

Insurers, the young, the uninsured and lawmakers are just a few of the groups sorting out what the implementation of health reform means for them as details emerge on changes to the system.

In a groundbreaking finding, a new medicine Galvus (vildagliptin) has been created for people with type 2 diabetes that would lower blood glucose levels without the side effects of other medications.

Calibra Medical announced today it received 510(k) clearance from the U.S.

Today's headlines include news about the politics of implementing the new health reform law as well as the ADA's 20th anniversary.

The treatment of diabetes was revolutionized in 1922 when insulin was isolated from dogs. Since then, significant advances in human medicine have made diabetes more manageable for patients.

One of the worst case scenarios that can happen to a diabetic is if he or she falls into a hypoglycemic coma.